Others have previously reported that disturbances in epigenetic balance promote carcinogenesis.3 Overexpression of EZH2 has been implicated in cancer progression.4 Our findings therefore suggest that HDAC inhibitors could be used as a chemo‐preventative tool in patients of high‐risk patients. This evidence concerns the gene HDAC9 and cancer.